688073 畢得醫藥
按盤價 
66.820 +1.520 (+2.328%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.943 | 5.705 | 5.261 | 10.793 | 19.650 |
| 總資產報酬率 ROA (%) | 4.808 | 4.859 | 4.590 | 8.941 | 13.803 |
| 投入資產回報率 ROIC (%) | 5.399 | 5.410 | 5.062 | 10.380 | 18.355 | 邊際利潤分析 |
| 銷售毛利率 (%) | 44.448 | 41.333 | 40.000 | 44.378 | 49.459 |
| 營業利潤率 (%) | 16.319 | 13.460 | 11.598 | 20.596 | 18.912 |
| 息稅前利潤/營業總收入 (%) | 17.022 | 11.450 | 8.833 | 18.457 | 19.725 |
| 淨利潤/營業總收入 (%) | 12.229 | 10.656 | 9.932 | 17.506 | 16.095 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.128 | 114.935 | 120.092 | 100.850 | 100.307 |
| 價值變動淨收益/利潤總額(%) | 4.977 | 3.221 | -7.042 | -0.235 | 0.356 |
| 營業外收支淨額/利潤總額(%) | -0.137 | -0.214 | -0.502 | 0.022 | -0.075 | 償債能力分析 |
| 流動比率 (X) | 4.556 | 6.388 | 8.223 | 9.012 | 3.277 |
| 速動比率 (X) | 2.777 | 4.189 | 5.680 | 6.917 | 1.367 |
| 資產負債率 (%) | 21.869 | 16.167 | 13.478 | 11.998 | 30.599 |
| 帶息債務/全部投入資本 (%) | 10.462 | 3.769 | 2.177 | 1.447 | 2.198 |
| 股東權益/帶息債務 (%) | 838.873 | 2,497.935 | 4,387.992 | 6,700.592 | 4,261.866 |
| 股東權益/負債合計 (%) | 357.264 | 518.561 | 641.976 | 733.488 | 226.804 |
| 利息保障倍數 (X) | 23.479 | -5.778 | -3.263 | -8.610 | 23.836 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 65.796 | 74.803 | 67.927 | 65.129 | 62.240 |
| 存貨周轉天數 (天) | 418.414 | 406.386 | 335.560 | 387.482 | 408.530 |
| 備註： | 即時報價更新時間為 25/12/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
